title: Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
abstract: This study analyzes the pathologic and molecular features of 5 cases of primary cutaneous large B-cell lymphoma of the leg (PCLBCL-leg), recently included in the European Organization for Research and Treatment of Cancer (EORTC) classification of primary cutaneous lymphoma. PCLBCL-leg accounts for 5% to 10% of all primary cutaneous B-cell lymphoma (PCBCL), usually affects elderly patients and carries a worse prognosis than other forms of PCBCL. It has been proposed that the malignant cells of PCLBCL-leg originate from germinal center (GC)-related cells, but their effective normal counterpart is unclear, and the rationale behind the inclusion of this lymphoma as a separate entity is based on its prognosis rather than on its proved histogenesis. All of our cases of PCLBCL-leg morphologically resembled diffuse large B-cell lymphoma (DLBCL), but to better define their histogenesis, we also analyzed various phenotypic and genotypic markers, including mutations of the Ig and of BCL-6 genes, as well as expression of the bcl-6, MUM1, and CD138/syndecan-1 proteins. Immunohistochemically, all of our cases stained for the L-26/CD20cy and CD79a antigens and expressed the bcl-2, bcl-6, and MUM-1 proteins but were negative for both the CD10/CALLA and CD138 antigens. With respect to molecular analysis, the lymphoma population of all PCLBCL-leg carried hypermutation of Ig genes, and all but 1 case also harbored mutations of the BCL-6 gene. Our results indicate that PCLBCL-leg are similar both under the morphofunctional and molecular profiles to most DLBCL of other sites. Thus, caution seems justified before definitely considering PCLBCL of the leg as a distinct entity.
authors.affiliation: Department of Pathology, IRCCS Policlinico S.Matteo/University of Pavia, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Paulli
authors.forename: Alessandra
authors.initials: A
authors.lastname: Viglio
authors.forename: Daniela
authors.initials: D
authors.lastname: Vivenza
authors.forename: Daniela
authors.initials: D
authors.lastname: Capello
authors.forename: Davide
authors.initials: D
authors.lastname: Rossi
authors.forename: Roberta
authors.initials: R
authors.lastname: Riboni
authors.forename: Marco
authors.initials: M
authors.lastname: Lucioni
authors.forename: Paolo
authors.initials: P
authors.lastname: Incardona
authors.forename: Emanuela
authors.initials: E
authors.lastname: Boveri
authors.forename: Mario
authors.initials: M
authors.lastname: Bellosta
authors.forename: Ester
authors.initials: E
authors.lastname: Orlandi
authors.forename: Giovanni
authors.initials: G
authors.lastname: Borroni
authors.forename: Mario
authors.initials: M
authors.lastname: Lazzarino
authors.forename: Emilio
authors.initials: E
authors.lastname: Berti
authors.forename: Elvio
authors.initials: E
authors.lastname: Alessi
authors.forename: Umberto
authors.initials: U
authors.lastname: Magrini
authors.forename: Gianluca
authors.initials: G
authors.lastname: Gaidano
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000378:metabolism; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000032:analysis; D004268:DNA-Binding Proteins / Q000235:genetics; D005260:Female; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry; D007866:Leg; D016393:Lymphoma, B-Cell / Q000235:genetics / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000235:genetics / Q000473:pathology*; D008297:Male; D011518:Proto-Oncogene Proteins / Q000235:genetics; D051560:Proto-Oncogene Proteins c-bcl-6; D012878:Skin Neoplasms / Q000235:genetics / Q000473:pathology*; D014157:Transcription Factors / Q000235:genetics
chemical_list: D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; D051560:Proto-Oncogene Proteins c-bcl-6; D014157:Transcription Factors